Article highlights Blood parameters such as RBCs, Hb, HCT and MCV levels were significantly decreased in COVID-19 patients compared with a control group. The interaction between decreased lymphocyte levels and increased white blood cell counts in individuals with COVID-19 indicates a complex immune response. Research findings indicate that among ICU- patients, males are more prone to experiencing severe illness due to COVID-19 when compared with females. Conversely, among patients outside of ICU settings, studies demonstrate a higher prevalence of female COVID-19 cases as opposed to males. The observed decrease in lymphocyte count among ICU patients could signal immune dysfunction or suppression. An elevated CRP level in conjunction with disease severity underscores its potential as an early indicator of the inflammatory state linked to the progression of COVID-19. Ferritin levels are elevated in non-ICU patients in contrast to ICU patients implies that ferritin may not serve as a dependable indicator of disease severity in COVID-19. LDH levels could indicate that LDH by itself may not be a robust indicator of ICU admission among COVID-19 patients in this research. Detectable IgM or IgG antibodies tended to exhibit lower levels of HCT, lymphocytes and WBC count, along with elevated CRP, LDH and serum ferritin levels. Undetectable IgM or IgG antibodies were primarily linked to lower hemoglobin levels, reduced red blood cell indices and decreased platelet count.
【저자키워드】 COVID-19, IgG, IgM, SARS-CoV2, Diagnosis, RT-PCR,